Texas Roadhouse (TXRH) Downgraded By Longbow Research; Last Week Zoetis Inc. (ZTS) Analysts

April 17, 2018 - By Henry Gaston

Zoetis Inc. (NYSE:ZTS) Logo

Among 21 analysts covering Zoetis Inc (NYSE:ZTS), 15 have Buy rating, 0 Sell and 6 Hold. Therefore 71% are positive. Zoetis Inc had 78 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Thursday, February 15 by Cowen & Co. The firm has “Buy” rating by Cantor Fitzgerald given on Monday, August 14. The firm earned “Buy” rating on Thursday, February 15 by Stifel Nicolaus. The rating was maintained by Craig Hallum with “Buy” on Tuesday, January 2. BMO Capital Markets maintained Zoetis Inc. (NYSE:ZTS) rating on Friday, November 3. BMO Capital Markets has “Market Perform” rating and $70 target. Jefferies maintained the shares of ZTS in report on Friday, April 13 with “Buy” rating. The firm earned “Hold” rating on Monday, August 7 by BMO Capital Markets. The rating was maintained by Jefferies on Thursday, November 16 with “Buy”. The firm earned “Buy” rating on Thursday, September 29 by Bank of America. Stifel Nicolaus maintained the shares of ZTS in report on Monday, October 23 with “Buy” rating. See Zoetis Inc. (NYSE:ZTS) latest ratings:

13/04/2018 Broker: Jefferies Rating: Buy New Target: $96.0000 Maintain
05/04/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $83 New Target: $89 Maintain
19/03/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Equal-Weight Old Target: $70 Downgrade
26/02/2018 Broker: Jefferies Rating: Buy New Target: $97.0 Maintain
16/02/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Hold Old Target: $76 New Target: $78 Maintain
16/02/2018 Broker: Piper Jaffray Rating: Buy New Target: $88.0 Maintain
15/02/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $86.0 Maintain
15/02/2018 Broker: Cowen & Co Rating: Buy New Target: $85.0 Maintain
13/02/2018 Broker: Barclays Capital Rating: Hold New Target: $71.0
16/01/2018 Broker: Stifel Nicolaus Rating: Buy New Target: $84.0 Maintain

In a a note sent to clients and investors today, Longbow Research downgraded shares of Texas Roadhouse (NASDAQ:TXRH) to a “Hold” rating.

Analysts await Texas Roadhouse, Inc. (NASDAQ:TXRH) to report earnings on April, 30 after the close. They expect $0.75 EPS, up 22.95% or $0.14 from last year’s $0.61 per share. TXRH’s profit will be $53.55M for 20.68 P/E if the $0.75 EPS becomes a reality. After $0.40 actual EPS reported by Texas Roadhouse, Inc. for the previous quarter, Wall Street now forecasts 87.50% EPS growth.

The stock decreased 0.58% or $0.36 during the last trading session, reaching $62.04. About 410,740 shares traded. Texas Roadhouse, Inc. (NASDAQ:TXRH) has risen 31.38% since April 17, 2017 and is uptrending. It has outperformed by 19.83% the S&P500.

Among 22 analysts covering Texas Roadhouse Inc. (NASDAQ:TXRH), 10 have Buy rating, 0 Sell and 12 Hold. Therefore 45% are positive. Texas Roadhouse Inc. has $67.0 highest and $38 lowest target. $55.70’s average target is -10.22% below currents $62.04 stock price. Texas Roadhouse Inc. had 62 analyst reports since August 5, 2015 according to SRatingsIntel. On Tuesday, April 17 the stock rating was downgraded by Longbow to “Neutral”. The firm has “Outperform” rating given on Tuesday, September 29 by Telsey Advisory Group. The company was initiated on Thursday, March 15 by Mizuho. Jefferies maintained Texas Roadhouse, Inc. (NASDAQ:TXRH) rating on Monday, October 30. Jefferies has “Sell” rating and $41.0 target. The stock of Texas Roadhouse, Inc. (NASDAQ:TXRH) has “Underperform” rating given on Tuesday, July 26 by Jefferies. The stock has “Sector Perform” rating by RBC Capital Markets on Tuesday, November 3. Oppenheimer maintained the stock with “Hold” rating in Tuesday, August 1 report. The company was upgraded on Tuesday, January 23 by Credit Suisse. The firm earned “Buy” rating on Wednesday, January 3 by Stifel Nicolaus. The stock has “Hold” rating by Canaccord Genuity on Tuesday, August 1.

Texas Roadhouse, Inc., together with its subsidiaries, operates full-service casual dining restaurants in the United States and internationally. The company has market cap of $4.43 billion. The firm operates and franchises its restaurants under the Texas Roadhouse name. It has a 33.72 P/E ratio. It also operates sports restaurants under the BubbaÂ’s 33 name.

Investors sentiment decreased to 1.4 in Q4 2017. Its down 0.29, from 1.69 in 2017Q3. It fall, as 20 investors sold Texas Roadhouse, Inc. shares while 75 reduced holdings. 61 funds opened positions while 72 raised stakes. 60.90 million shares or 0.49% more from 60.60 million shares in 2017Q3 were reported. Northwestern Mutual Wealth Mgmt stated it has 0% in Texas Roadhouse, Inc. (NASDAQ:TXRH). Riverhead Capital Mgmt Ltd Llc holds 0.02% or 9,616 shares in its portfolio. Shelton Mgmt holds 0.01% or 4,276 shares. Eaton Vance Management holds 0.08% in Texas Roadhouse, Inc. (NASDAQ:TXRH) or 591,142 shares. Private Trust Na owns 9,709 shares for 0.11% of their portfolio. France-based Cap Fund Mngmt Sa has invested 0.01% in Texas Roadhouse, Inc. (NASDAQ:TXRH). Lord Abbett & Ltd stated it has 0.11% of its portfolio in Texas Roadhouse, Inc. (NASDAQ:TXRH). Bahl And Gaynor holds 0.06% or 102,863 shares in its portfolio. Bessemer Group holds 0.02% or 116,173 shares. Psagot House Limited has invested 0.21% in Texas Roadhouse, Inc. (NASDAQ:TXRH). 1.27 million were accumulated by Northern Tru. National Bank & Trust Of America De reported 0% in Texas Roadhouse, Inc. (NASDAQ:TXRH). Campbell Com Investment Adviser Ltd Liability Corporation owns 13,117 shares or 0.51% of their US portfolio. Brinker Cap Inc holds 0.01% of its portfolio in Texas Roadhouse, Inc. (NASDAQ:TXRH) for 4,315 shares. Architects stated it has 0.01% of its portfolio in Texas Roadhouse, Inc. (NASDAQ:TXRH).

Since December 12, 2017, it had 0 insider buys, and 9 selling transactions for $3.67 million activity. Jacobsen S. Chris sold $90,000 worth of Texas Roadhouse, Inc. (NASDAQ:TXRH) on Friday, January 26. 10,644 shares valued at $623,206 were sold by Colosi Scott Matthew on Thursday, February 15. ZARLEY JAMES R also sold $619,384 worth of Texas Roadhouse, Inc. (NASDAQ:TXRH) on Friday, February 23. Another trade for 1,300 shares valued at $66,118 was made by WIDMER KATHY on Tuesday, December 12. Catlett Celia sold 6,337 shares worth $355,569.

Investors sentiment increased to 1.13 in 2017 Q4. Its up 0.03, from 1.1 in 2017Q3. It increased, as 34 investors sold Zoetis Inc. shares while 251 reduced holdings. 80 funds opened positions while 241 raised stakes. 429.52 million shares or 2.55% less from 440.74 million shares in 2017Q3 were reported. Hl Fin Svcs Limited Liability owns 126,428 shares. Bankshares stated it has 0.04% in Zoetis Inc. (NYSE:ZTS). Canada Pension Plan Invest Board accumulated 307,509 shares. Mutual Of America Cap Mngmt Llc has invested 0.08% in Zoetis Inc. (NYSE:ZTS). Bluestein R H And stated it has 0.02% in Zoetis Inc. (NYSE:ZTS). Fny Managed Accounts Ltd Liability Corporation reported 0% in Zoetis Inc. (NYSE:ZTS). 200 are held by Focused Wealth Mngmt. State Of Wisconsin Board holds 0.12% or 614,772 shares in its portfolio. Gilder Gagnon Howe Com Ltd Llc reported 0% of its portfolio in Zoetis Inc. (NYSE:ZTS). Ngam Advsrs Lp invested in 0.1% or 134,442 shares. Ami Asset Management invested in 590,837 shares or 2.94% of the stock. Appleton Partners Ma stated it has 0.89% of its portfolio in Zoetis Inc. (NYSE:ZTS). Smithfield holds 1,209 shares or 0.01% of its portfolio. Stephens Ar has invested 0.1% in Zoetis Inc. (NYSE:ZTS). Nippon Life Global Americas holds 0.39% of its portfolio in Zoetis Inc. (NYSE:ZTS) for 67,550 shares.

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. The company has market cap of $41.27 billion. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. It has a 48.61 P/E ratio. The firm also provides medicated feed additives that offer medicines to livestock; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products.

Texas Roadhouse, Inc. (NASDAQ:TXRH) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Henry Gaston

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: